MAPT and Alzheimer disease: A recent clinical study showed that AD-EPI+ patients, compared to AD-EPI− patients, have higher bilateral Aβ burden particularly in the medial temporal, lateral temporal, frontal, and medial parietal regions, as well as asymmetrical tau burden, which is higher in the epileptogenic hemisphere45.